Results 81 to 90 of about 44,133 (142)

Comparative Efficacy of Minoxidil and 5-Alpha Reductase Inhibitors Monotherapy for Male Pattern Hair Loss: Network Meta-Analysis Study of Current Empirical Evidence. [PDF]

J Cosmet Dermatol
Gupta AK, Bamimore MA, Williams G, Talukder M.   +3 more
europepmc   +1 more source

5-Alpha Reductase Inhibitors on Hypersexuality During the Manic Phase of Bipolar and Psychotic Patients; New Insight to a Well-Known Medicines. [PDF]

Iran J Pharm Res
Mahmoudi Meymand M, Mohammad Soleymani S, Esmaily H.   +2 more
europepmc   +1 more source

Do 5-Alpha Reductase Inhibitors Influence the Features of Suspicious Lesions on Magnetic Resonance Imaging and Targeted Biopsy Results for Prostate Cancer Diagnosis? [PDF]

Diagnostics (Basel)
Savin Z, Shem-Tov Dlugy A, Grinbaum M, Mendelson T, Lifshitz K, Mano R, Keren-Paz G, Bar-Yosef Y, Neeman R, Yossepowitch O, Dekalo S.   +10 more
europepmc   +1 more source

Persistent Sexual Dysfunction and 5 Alpha Reductase Inhibitors

The Journal of Sexual Medicine, 2012
openaire   +2 more sources

The impact of preoperative 5-alpha reductase inhibitors on functional outcomes and health-related quality of life following radical prostatectomy - A propensity score matched longitudinal study. [PDF]

World J Urol
Westhofen T, Frank K, Buchner A, Becker A, Eismann L, Rodler S, Aydogdu C, Berg E, Jokisch F, Kazmierczak PM, Stief CG, Kretschmer A.   +11 more
europepmc   +1 more source

External validation of the barcelona magnetic resonance imaging predictive model for detecting significant prostate cancer including men receiving 5-alpha reductase inhibitors. [PDF]

World J Urol
Morote J, Borque-Fernando Á, Esteban LM, Picola N, Muñoz-Rodriguez J, Paesano N, Ruiz-Plazas X, Muñoz-Rivero MV, Celma A, Manuel GG, Miró B, Abascal JM, Servian P.   +12 more
europepmc   +1 more source

Early embryonic exposure of freshwater gastropods to pharmaceutical 5-alpha-reductase inhibitors results in a surprising open-coiled "banana-shaped" shell. [PDF]

Sci Rep, 2019
Baynes A, Montagut Pino G, Duong GH, Lockyer AE, McDougall C, Jobling S, Routledge EJ.   +6 more
europepmc   +1 more source

Role of 5-alpha reductase inhibitors in the prevention of prostate cancer

Indian Journal of Urology, 2011
Bhupendra P Singh, S N Sankhwar, Apul Goel   +2 more
doaj  

Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia. [PDF]

Clin Epidemiol, 2017
Hagberg KW, Divan HA, Fang SC, Nickel JC, Jick SS.   +4 more
europepmc   +1 more source

Use of 5-alpha-reductase inhibitors as alternatives to luteinizing-hormone releasing hormone (LHRH) analogs or anti-androgens for prostate downsizing before brachytherapy. [PDF]

Pract Radiat Oncol, 2018
Bae HJ, Mian O, Vaidya D, DeWeese TL, Song DY.   +4 more
europepmc   +1 more source